فهرست:
فصل اول: معرفی پژوهش.........................................................................................................................1
1-1بیان مسئله:.............................................................................................................................2
1-2 اهداف پژوهش....................................................................................................................5
1-3 سوالات و فرضیات پژوهش...............................................................................................6
فصل دوم: دانستنی های موجود در پژوهش............................................................................................7
2-1 بخش اول: چارچوب پنداشتی...........................................................................................8
2-1-1 غده تیروئید...................................................................................................8.
2-1-2 هایپوتیروئیدی................................................................................................17
2-1-3 دیس لیپیدمی.............................................................................................28
2-2 بخش دوم: مروری بر مطالعات انجام شده.........................................................................42
فصل سوم: مواد و روش کار:..................................................................................................................46
فصل چهارم: نتایج...................................................................................................................................53
فصل پنجم: بحث.................................................................................................................................. 70
فصل ششم: نتیجه گیری و پیشنهادات..................................................................................................75
منابع.....................................................................................................................................................76
منبع:
Dan. Longo, Anthony S. Fauci, Dennis L.Kasper, StephenL.Hauser, J.LarryJameson, JosephLoscalzo,etal Harrison's Principles of Internal Medicine.18th ed. Tehran:Andishe rafi;1388.p.477-499.[Text in Persian]
Michael T.McDermott٫E.Chester Ridgway.subclinical hypothyroidism is mild thyroid failure and should be treated . The journal of clinical endocrinology & metabulism .2001;32:123.
Charles j.Glueck.Cholesterol. center jewish hospital .
4. B.A. ryff.De leche.J jestaube ٫et al. LDL/HDL –change in subclinicsl hypothyroidism:possible risk factors for coronary heart disease. Department of internal medicine,university hospital of basel ch-4031. [serialonline].
5.Teixeria PFS٫Reuters VS٫Ferreira MM٫ et al.treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo –controlled double -blind clinical trial .department de medicina intera.hospital de terrassa. [serialonline].
6. Wiseman SA, Powell JT, Humphries SE, Press M. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab. 1993 Jul;77(1):108
7. Shlomo Melmed, Kenneth S. Polonsky, MD, P. Reed MD Larsen and Henry M. Kronenberg.williams text book of endocrinology.12th edition.chapter 12.893-7
8. Baliant Kacsoh.Endocrine physiology.fist ed.Mc Graw – Hill.2008.p.202-213
9. Ganoge W.F.Review of medical physiology.2 ed.parentic-Hall.2004.p.1677-79
10. Moradi sedighe,Hedaiati Mahdi,Azizi fereidun.Effect of LT4 treatment on clinical and labratuar finding in subclinical hypothyroidism patients. Iran`s endocrine and metabolism magazine.2004;1:27-28
11.Shahbazian Hajie,Mohammadi Somaye,et al.effect of 6 month L-thyroxin therapy on lipid profile of subclinicsl hypothyroidism.department of endocrinology ahvaz.2009;87:22
12. Razavi s٫Ingoe L٫Keeka G.the beneficial effect of L-thyroxin on cardiovascular risk factors٫endothelial function٫and quality of life in subclinical hypothyroidism .the journal of Queen Elizabeth Hospital,Uniithed Kingdom.2009 october;24:145
13. Tunbridge WM, Evered DC, Hall R, Bird T.Evans JG.French JM.Young E . The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 ; 7:481– 493
14. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P 1979 The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly.JAMA. 242:247–250
15. Ineck BA, Ng TM. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother. 2003 May;37(5):725-30.
16.Bastenie PA, Vanhaelst L, Neve P. Coronary-artery disease in hypothyroidism. Lancet. 1967 Dec 9;2(7528):1221-2.
17. Fowler PS, Swale J. Premyxoedema and coronary-artery disease. Lancet. 1967 May 20;1(7499):1077-9.
18. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004 May;89(5):2099-106.
19 . Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6.
20. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med. 2006 Jul;260(1):53-61
21. Pazos F,Alvarez jj,Rubies-part j, et all.long term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J clin endocrinal metab 1995;80:562.
22. Ito M,Arishima T,Kudo T,et al.Effect of levo-thyroxin replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.J Clin Endocrinal metab 2007;92:608
23. de Brulin TW,Van barlingen H,Van Linde-sibenius Trip M. et all. Lipoprotein (a) and apolipoprotein B plasma consentraitions in hypothyroid ,euthyroid and hyperthyroid subjects. J clin endocrinal metab 1993;76:121.
24.Martinez-Triguero ML,Hernandez-Mijares A,Nguyen TT,et al.effect of thyroid hormone replacement on lipoprotein(a).lipid and apolipoprotein in subjects with hypothyroidism. Myo Clin proc 1998;73:837
25 .Gilbert A.Geraldo Medeiros-neto,Juliana C Vinagre,et al.lipid metabolism in subclinical hypothyroidism.2011;21:4
26. Efstathiadou Z,Bitsis S,Milionis HJ, et al.lipid profile in subclinical hypothyroidism. Eur J Endocrinol 2001;145:705-10
27. Ross DS 2000 Subclinical hypothyroidism. In: Braverman LE, Utiger RU, eds. Werner and Ingbar’s the thyroid, 8th Ed. New York: Lippincott-Williams & Wilkins; 1001–1006
28. Ito M,Takamatsu J,Masuo T,et al.Serum concentration of remnant-like particles in hypothyroid patients before and after thyroxin replacement. Clin Endocrinal (oxf)2003;58:621
29.Biondi B,Cooper DS.the clinical significance of subclinical thyroid dysfunction.Endocr Rev 2008:29:76
30.Surk MI,Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population:implications for the prevalence of subclinical hypothyroidism.J clin Endocrinol metab 2007:92:4575.
31.Mc Dermott MT,Ridgway EC ,subclinical hypothyroidism is mild thyroid failure and should be treated.J Clin Endocrinol metab 2001:86:4585.
32.Gharib H,Tuttle RM,Baskin HJ,et al.subclinical thyroid dysfunction :a joint statement on management from the American association of clinical Endocrinologist,the American Thyroid Association ,and the Endocrine Society .J Clin Endocrinol Metab 2005:90:581.
33. Cooper DS,Halpren R,Wood LC,Levin AA,Ridgway EC.L-Thyroxin therapy in subclinical hypothyroidism.Ann intern med1984;101:18-24
34. Bemben DA.Winn P,Hamm RM,Morgan L et al. Thyroid disease in the elderly.part 1.prevalence of undiagnosed hypothyroidism.J Fam Pract 1994;38:577-82
35.Serter R.Demirbas B,Cakal E,Aral Y. The effect of L-thyroxin replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 2004;27(10):897-903
36.Keventy J,Heldgaard PE,Gram J et al.Subclinical hypothyroidism is associated with low-grade inflammation,increased triglyceride level and predictes cardiovascular disease .Clin Endocrinol(oxf) 2004;61(2):223-8
37.Haggerty JJ Jr,Evans DL,Prange A et al.organic brain syndrome associated with marginal hypothyroidism.AMJ psychologyn1986;143:785-6
38.Friedwald WT,Levy RI .Estimation of the concentration of low-density lipoprotein cholstrol in plasma.Clin chem 197;18:499-502